Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
105.00    0.50 (0.48%)
Bid:
104.50
Ask:
105.00
Spread: 0.50 (0.478%)
Market Cap: £306.84m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

Trading Update

8 Dec 2025 07:00

RNS Number : 5389K
Big Technologies PLC
08 December 2025
 

Big Technologies plc

("Big Technologies" or "the Company", together with its subsidiaries the "Group")

Trading Update

Rickmansworth - 8 December 2025 - Big Technologies plc (AIM: BIG), a leading provider of electronic monitoring solutions provides the following update to 8th December 2025.

· New Business Wins in Lithuania, Latvia, and Pierce County (Washington state), subject to final contract. New contract signed in Prince Edward Island, Canada. All of the contracts and awards are expected to generate ARR to the group over the course of 2026 as they come online and reduce customer concentration. The largest award, Lithuania, will deliver an initial ARR of £0.6m expected to materialise in 2026, with the opportunity to grow to a total contract value of up to c. €6m over a three- year term.

 

· Partnership agreed with US based Recovery Monitoring Solutions ('RMS'). Buddi has signed a strategic partnership with RMS to provide state-of-the-art alcohol monitoring and GPS products to their clients. RMS has a 32-year history of delivering innovative solutions to their customers, and we are pleased to be working with them to increase their product portfolio, and further expand Buddi's reach in the USA.

 

· Product Certification: The Group has recently developed a new product to measure breath alcohol, called 'AlcoBreath' which has recently received FCC ("Federal Communications Commission") approval in the USA. The unit combines breath alcohol detection, real time GPS tracking, and facial recognition in a robust, compact handheld device. The Group believes there is a significant market, particularly in the USA, for compliance-based alcohol monitoring.

The Group expects to release its full year trading update at the end of January 2026 and new contract wins underpin confidence in the Group's trading in line with market expectations.

Ian Johnson, Big Technologies CEO, said:

"We are continuing to progress our transformation programme, strengthening our organisation and delivering profitable growth. We are delighted with the recent awards and validation of the competitiveness of the Buddi proposition to customers globally.

The Group remains well-positioned with the financial flexibility underpinned by a strong balance sheet and operational cashflow to continue to invest in product and market development. The electronic monitoring market continues to experience significant tailwinds. The Company has a clear growth strategy and market leading products, which places the Group in a strong position to compete for new business globally.

The Group has seen rapid progress in the second half of 2025, underpinned by investments made to strengthen the Group organisationally and operationally. The performance across the Group, driven by management actions and strategic initiatives has built confidence in meeting our full year guidance for revenue and adjusted EBITDA1."

 

1The company has compiled forecasts from five analysts with current market forecasts for 2025 revenue to be in the range of £48.5m to £49.5m, with a consensus of £49.1m, and for adjusted EBITDA to be in the range of £23.7m to £24.5m, with a consensus of £24.1m.

-Ends-

 

Enquiries

Big Technologies plc

+44 (0) 192 360 1910

Ian Johnson (Chief Executive Officer)

Mike Johns (Chief Financial Officer)

Zeus (Nominated Adviser and Joint Broker)

 +44 (0) 203 829 5000

Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

Singer Capital Markets (Joint Broker)

 +44 (0) 207 496 3000

James Moat / James Todd (Investment Banking)

 

About

Big Technologies is a market leader in the remote personal monitoring industry, operating under the trusted 'Buddi' brand. The Company delivers innovative, high-quality solutions that combine advanced hardware and software to support the monitoring of individuals in the criminal justice sector.

Through its integrated technology platform, Big Technologies offers state-of-the-art Electronic Monitoring solutions on a subscription-based, SaaS-like model. This platform is highly flexible and scalable, enabling tailored deployments across diverse use cases and geographies.

The Company's core technologies are designed to meet the evolving needs of governments and agencies, ensuring safety, compliance, and peace of mind through reliable, real-time monitoring.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVAFELEIIE
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
30th Mar 20267:00 amRNSAudited Results for the year to 31 December 2025
26th Feb 20267:00 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBoard Changes
2nd Feb 20267:00 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSFurther Litigation Update
10th Dec 20259:41 amRNSHolding(s) in Company
9th Dec 20259:42 amRNSHolding(s) in Company
8th Dec 20257:00 amRNSTrading Update
3rd Nov 20252:54 pmRNSDirector and PDMR Dealings
16th Oct 20257:01 amRNSWithdrawal of General Meeting Requisition Notice
16th Oct 20257:00 amRNSBoard Changes
3rd Oct 20257:00 amRNSBoard Changes
30th Sep 20257:00 amRNSInterim Results for the 6 months to 30 June 2025
26th Sep 20257:00 amRNSNotice of Requisition of a General Meeting
12th Sep 20257:00 amRNSLitigation Update
20th Aug 20257:00 amRNSChange of Website Address
6th Aug 20257:00 amRNSBoard Change and Issue of Shares
1st Aug 20257:00 amRNSIssue of Shares
28th Jul 20257:00 amRNSBoard Changes
22nd Jul 20257:00 amRNSTrading Update
18th Jun 20252:53 pmRNSResult of AGM and Litigation Update
13th Jun 20258:12 amRNSPublication of Letter to Shareholders
10th Jun 20251:27 pmRNSSuspension of Voting Rights and Letter Response
5th Jun 20257:00 amRNSLitigation Update
22nd May 20259:45 amRNSDirector Dealings
22nd May 20257:00 amRNS2024 Audited Results and Notice of AGM
16th May 20257:00 amRNSAppointment of Joint Corporate Broker
8th May 20257:00 amRNSBoard and Management Changes and Trading Update
7th Apr 20257:00 amRNSAppointment of Non Executive Director
3rd Apr 20257:00 amRNSUpdate re: CEO Dismissal
1st Apr 20257:00 amRNS-RContract Award
1st Apr 20257:00 amRNSDirectorate Change
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20255:20 pmRNSCEO Dismissal and Commencement of Litigation
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 202511:13 amRNSLitigation Update
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 202512:51 pmRNSCEO Suspension
18th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.